3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
3
Unknown
2
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
10
Head & Neck
2
Genitourinary
2
Tumor-Agnostic
1
Thoracic
1
Other hematologic neoplasm
1
Other
1
Gynecologic
1
Conditions
Motor Activity
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Smoking
1
Risk Reduction Behavior
1
Postoperative Complications
1
Patient Preference
1
Obesity
1
Malnutrition
1
Alcohol Drinking
1
Interventions
Docetaxel
33
Radiosurgery
23
Radiotherapy
21
Sunitinib
20
pembrolizumab
18
Gemcitabine
16
Cisplatin
16
Androgen Antagonists
15
Nivolumab
14
enzalutamide
13
Goserelin
13
Prednisone
12
Leuprolide
12
Blood Specimen Collection
12
Abiraterone Acetate
12
bicalutamide
11
aldesleukin
11
Surveys and Questionnaires
11
Cyclophosphamide
11
Gonadotropin-Releasing Hormone
10
Bevacizumab
10
Multiparametric Magnetic Resonance Imaging
9
Carboplatin
9
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
8
Triptorelin Pamoate
8
Radiotherapy, Intensity-Modulated
8
Filgrastim
8
Epirubicin
8
Chemotherapy, Adjuvant
8
Brachytherapy
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Preoperative Exercise
×
Genitourinary
×
Clear all
NCT04088968
2024-03-22
STRONG-CS
Bispebjerg Hospital
Phase NA
Unknown
100 enrolled
NCT05480735
2022-10-31
ENHANCE
The Netherlands Cancer Institute
Phase NA
Unknown
154 enrolled